|
Exendin 9-39 Clinical Trials
3 actively recruiting trials across 2 locations
▲ +1 trial since August 2026
Also known as: no other name for exendin-(9-39)
Pipeline
Early 1: 1Phase 1: 1Phase 2: 1
Top Sponsors
- Mayo Clinic2
- The University of Texas Health Science Center at San Antonio1
Indications
- Diabetes2
- Post-bariatric Surgery1
- Gestational Diabetes Mellitus1
- PreDiabetes1
- Weight Loss1
Rochester, Minnesota2 trials
Islet Function in Gestational Diabetes
Mayo Clinic
Phase 1
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes
Mayo Clinic in Rochester
Phase 2
San Antonio, Texas1 trial
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
Texas Diabetes Institute - University Health System
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.